These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7940802)

  • 21. Follow-up of patients with borderline changes in renal allograft biopsies: clinical outcome and evaluation of other histological features in addition to tubulitis.
    Papadimitriou J; Drachenberg C; Anderson L; Bartlett S; Johnson L; Klassen D; Hoehn-Saric E; Weir M; Schweitzer E
    Transplant Proc; 1996 Feb; 28(1):517-8. PubMed ID: 8644334
    [No Abstract]   [Full Text] [Related]  

  • 22. Classic lamellar proteinaceous medial hyalinosis of small arteries and arterioles seen in an allograft without cyclosporine exposure.
    Amin K; Salinas-Madrigal L; Bastani B
    Transpl Int; 2005 Jun; 18(6):759-60. PubMed ID: 15910308
    [No Abstract]   [Full Text] [Related]  

  • 23. The natural history of renal function following orthotopic heart transplant.
    Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
    Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic cyclosporine nephropathy in renal transplantation.
    Bennett WM; DeMattos A; Meyer MM; Andoh T; Barry JM
    Transplant Proc; 1996 Aug; 28(4):2100-3. PubMed ID: 8769166
    [No Abstract]   [Full Text] [Related]  

  • 25. Interlobular hyaline arteriopathy reflects severe arteriolopathy in renal allografts.
    Oguchi H; Sakai K; Yamaguchi Y; Mikami T; Nemoto T; Ohashi Y; Kawamura T; Muramatsu M; Itabashi Y; Shinoda K; Hyodo Y; Takahashi Y; Kawaguchi Y; Onishi H; Hamasaki Y; Shibuya K; Shishido S
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():58-62. PubMed ID: 29968404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posttransplant diabetes mellitus in cyclosporine-treated renal allograft patients: a case-control study.
    Copstein LA; Zelmanovitz T; Gonçalves LF; Manfro RC
    Transplant Proc; 2004 May; 36(4):882-3. PubMed ID: 15194302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of infections in renal transplant recipients treated with cyclosporine.
    Carmellini M; Romagnoli J; Pietrabissa A; Di Stefano R; Oleggini M; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1994 Oct; 26(5):2658-9. PubMed ID: 7940832
    [No Abstract]   [Full Text] [Related]  

  • 28. Renal transplantation: nifedipine for the nonstarters? A prospective randomised study.
    Donnelly PK; Feehally J; Jurewicz A; Furness P; McCullough T; Harper SJ; Moorhouse J; Morgan J; Kehinde EO; Horsburgh T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):600-1. PubMed ID: 8438431
    [No Abstract]   [Full Text] [Related]  

  • 29. Thrombotic microangiopathy in renal transplant recipients treated with cyclosporin A.
    Zent R; Katz A; Quaggin S; Cattran D; Wade J; Cardella C; Zaltzman J; Fenton S; Cole E
    Clin Nephrol; 1997 Mar; 47(3):181-6. PubMed ID: 9105765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A long-term study on hyperlipidemia in stable renal transplant recipients.
    Tse KC; Lam MF; Yip PS; Li FK; Lai KN; Chan TM
    Clin Transplant; 2004 Jun; 18(3):274-80. PubMed ID: 15142048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of 214 percutaneous allograft renal biopsies.
    Kim HC; Park SB; Lee SH; Cho WH; Park CH; Park KK
    Transplant Proc; 1994 Aug; 26(4):2197-8. PubMed ID: 8066719
    [No Abstract]   [Full Text] [Related]  

  • 32. IgA nephropathy in renal transplant recipients: is it a significant cause of allograft failure?
    Park SB; Joo I; Suk J; Cho WH; Park CH; Kim SP; Park KK; Kim HC
    Transplant Proc; 1996 Jun; 28(3):1540-2. PubMed ID: 8658777
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of subclinical rejection on renal allograft histology and function at 6 months.
    Rush D; Jeffery J; Trpkov K; Solez K; Gough J
    Transplant Proc; 1996 Feb; 28(1):494-5. PubMed ID: 8644325
    [No Abstract]   [Full Text] [Related]  

  • 34. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA; Sally S; Foda MA; Sobh MA; el-Sherif AK; Ghoneim MA
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute vascular rejection with hemolytic uremic syndrome in kidneys from non-heart-beating donors: associated with secondary grafts and early cyclosporine treatment?
    Schlumpf R; Candinas D; Weder W; Röthlin M; Zollinger A; Bleisch J; Retsch M; Largiadèr F
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1518-21. PubMed ID: 8442172
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of recurrent focal segmental glomerulosclerosis with high-dose cyclosporine A and plasmapheresis.
    Mowry J; Marik J; Cohen A; Hogg R; Sahney S; Ettenger R
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1345-6. PubMed ID: 8442138
    [No Abstract]   [Full Text] [Related]  

  • 37. Proteinuria after renal allograft: assessment based on severity and causes.
    Jeong HJ; Kim YS; Oh CK; Park K; Choi IJ
    Transplant Proc; 1994 Aug; 26(4):2132-3. PubMed ID: 8066695
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cyclosporine nephrotoxicity (chronic arteriolopathy, glomerulopathy)].
    Matsushima H; Hishida A
    Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):553-5. PubMed ID: 9277814
    [No Abstract]   [Full Text] [Related]  

  • 39. Protocol biopsies after kidney transplantation.
    Böhmig GA; Regele H; Hörl WH
    Transpl Int; 2005 Feb; 18(2):131-9. PubMed ID: 15691264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pattern of endothelin immunostaining during rejection episodes after kidney transplantation.
    Watschinger B; Vychytil A; Attar M; Wagner D; Schuller M; Hartter E; Ulrich W
    Clin Nephrol; 1994 Feb; 41(2):86-93. PubMed ID: 8004834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.